Buccal mucosa as a route for drug delivery: Mechanism, design and evaluation

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Volumn 2, Issue 3, 2011, Pages 358-372

  Singh, Stuti Gupta ^a   Singh, Ravindra Pal ^b   Gupta, Shivjee Kumar ^a   Kalyanwat, Renu ^a   Yadav, Sudhir ^a  

^a JAIPUR NATIONAL UNIVERSITY   (India)

^b SURESH GYAN VIHAR UNIVERSITY   (India)

Author keywords

Bioadhesive; Buccal mucosa; Sustain

Indexed keywords

ACICLOVIR; ARECOLINE; BUPRENORPHINE; BUSERELIN; CALCITONIN; CARBAMAZEPINE; CARBOMER; CODEINE; DODECYL SULFATE SODIUM; ETRETIN; GLUCAGON LIKE PEPTIDE; GLYCERYL TRINITRATE; INSULIN; LECTIN; LEUCINE ENKEPHALIN; MELATONIN; METOCLOPRAMIDE; METRONIDAZOLE; MORPHINE SULFATE; NALBUPHINE; NICOTINE; NIFEDIPINE; OCTREOTIDE; OMEPRAZOLE; OXYTOCIN; PINDOLOL; PIROXICAM; PROPRANOLOL; TIMOLOL; UNINDEXED DRUG;

CHEEK MUCOSA; DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG DOSAGE FORM; DRUG METABOLISM; DRUG PENETRATION; DRUG RELEASE; ENDOCYTOSIS; FLOW KINETICS; GASTROINTESTINAL TRACT; HUMAN; HYDROPHILICITY; IONIZATION; LIPID BILAYER; MOUTH MUCOSA; MUCUS SECRETION; NONHUMAN; REVIEW; SALIVARY GLAND; THERMODYNAMICS; TOXICITY;

EID: 79960965451     PISSN: None     EISSN: 09758585     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Aungst BJ. Pharmacol Exp Ther 1988; 244 (1): 23-27.
2. Shao Z and Mitra AK. Pharm Res 1992; 9 (9)
3. Soyani AP and Chien YW. Drug Carrier Sys 1996; 13 (1-2): 885-184.
4. Shimamoto T. Androl J 1987; 8 (1): S14-S16.
5. Dal negrar et al. Int J Clin Pharmacol Ther Toxicol 1991; 29(4): 144-146.
6. Streisand J et al. Anesthesiology 1991; 75: 223-229.
7. Squier CA. Crit Rev Oral Boil Med 1991; 2 (1): 13-32.
8. Harris D and Robinson JR. J Pharm Sci 1992; 81(1): 1-10.
9. Ishida M et al. Chem Pharm Bull 1982; 30: 980-984.
10. Collins AEM et al. Int J Pharm 1989; 51: 103-114.
11. Elkayam R et al. J Controlled Release 1988; 7: 231-236.
12. Samaranayake L and M Ferguson. Adv Drug Del Dev 1994; 13: 161-179.
13. Nagai T. Controlled Release 1985; 2: 121-134.
14. Nagai T and Machida Y. Pharm Int 1985; 196-200.
15. Gandhi RB and Robinson JR. Adv Drug Del Rev 1994; 13: 43-74.
16. Dowtrh ME et al. Pharm Res 1992; 9 (9): 1113-1122.
17. Tabak LA et al. J Oral Pathol 1982; 11: 1-17.
18. Tavakoli- Saberi MR and Audus KL. Pharm Res 1989; 6: 160-162.
19. Tavakoli-Saberi MR et al. Pharm Res 1989; 6; 197.
20. Leipold HR and Quadros E. Proc Int Symp Contr Rel Bioact Mater 1993; 20: 242-243.
21. Jacobsen J et al. Int J Pharm 1995; 125: 165-184.
22. Jacobsen J et al. Int J Pharm 1996; 141: 217-225.
23. Jacobsen J et al. Eur J Oral sci 1999; 107: 138-146.
24. Nielsen HM and Rsssing MR. Int J Pharm 1999; 185: 215-225.
25. Nielsen HM et-al. J Controlled Release 1999; 60: 223-233.
26. Beckett AH and Triggs EJ. J Pharm Pharmacol 1967; 19 (suppl): 31S-41S.
27. Schurmann W and Turner P. J Pharm Pharmacol 1978; 30: 137-147.
28. Tucker IG. J Pharm Pharmacol 1988; 40: 679-683.
29. Barsuhn CL et al. Clin Pharmacol Ther 1988; 44: 225-231.
30. Gonzalez- Younes I et al. J Pharm Sci 1991; 80: 820-823.